Photo by nci from unsplash
2521Background: Most targeted treatments are associated with biomarkers, predictive of drug response. Although bevacizumab is widely used, there are still no available biomarkers. Given the need of... Click to show full abstract
2521Background: Most targeted treatments are associated with biomarkers, predictive of drug response. Although bevacizumab is widely used, there are still no available biomarkers. Given the need of...
Keywords:
predict response;
bevacizumab;
response;
polymorphisms predict;
vegfa icam1;
icam1 polymorphisms
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!